Cubist Systematic Strategies’s Neurogene NGNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,720
| Closed | -$546K | – | 2237 |
|
|
2024
Q1 | $546K | Buy |
+10,720
| New | +$546K | ﹤0.01% | 1359 |
|
|
2023
Q2 | – | Sell |
-672
| Closed | -$9.41K | – | 2759 |
|
|
2023
Q1 | $9.41K | Buy |
+672
| New | +$9.41K | ﹤0.01% | 2684 |
|
|
2022
Q4 | – | Sell |
-306
| Closed | -$4K | – | 3219 |
|
|
2022
Q3 | $4K | Sell |
306
-163
| -35% | -$2.13K | ﹤0.01% | 3525 |
|
|
2022
Q2 | $10K | Sell |
469
-1,246
| -73% | -$26.6K | ﹤0.01% | 3729 |
|
|
2022
Q1 | $64K | Buy |
1,715
+751
| +78% | +$28K | ﹤0.01% | 3309 |
|
|
2021
Q4 | $93K | Buy |
964
+769
| +394% | +$74.2K | ﹤0.01% | 3214 |
|
|
2021
Q3 | $28K | Sell |
195
-80
| -29% | -$11.5K | ﹤0.01% | 2874 |
|
|
2021
Q2 | $51K | Buy |
275
+220
| +400% | +$40.8K | ﹤0.01% | 2790 |
|
|
2021
Q1 | $14K | Buy |
55
+26
| +90% | +$6.62K | ﹤0.01% | 2777 |
|
|
2020
Q4 | $8K | Buy |
+29
| New | +$8K | ﹤0.01% | 2520 |
|
|
2020
Q3 | – | Sell |
-667
| Closed | -$221K | – | 2580 |
|
|
2020
Q2 | $221K | Buy |
667
+181
| +37% | +$60K | ﹤0.01% | 1990 |
|
|
2020
Q1 | $111K | Sell |
486
-601
| -55% | -$137K | ﹤0.01% | 1889 |
|
|
2019
Q4 | $268K | Buy |
+1,087
| New | +$268K | ﹤0.01% | 1909 |
|
|
2018
Q2 | – | Sell |
-304
| Closed | -$86K | – | 1954 |
|
|
2018
Q1 | $86K | Sell |
304
-133
| -30% | -$37.6K | 0.01% | 1615 |
|
|
2017
Q4 | $103K | Buy |
+437
| New | +$103K | 0.01% | 1678 |
|